-
261
Neutropenic Enterocolitis in a Pediatric Heart Transplant Recipient on Multiple Immunosuppressants
Published 2018-01-01“…Although NE does not typically affect solid organ transplant patients, this patient had a variety of risk factors that may have predisposed her to development of NE such as severe neutropenia, supratherapeutic tacrolimus level, immunosuppression with cytotoxic agents, and elevated Epstein-Barr viral load. …”
Get full text
Article -
262
Interferon-gamma rescues dendritic cell calcineurin-dependent responses to Aspergillus fumigatus via Stat3 to Stat1 switching
Published 2025-02-01“…These findings provide key insight into the mechanisms of immunotherapy in organ transplant recipients with invasive fungal diseases.…”
Get full text
Article -
263
The Challenge of Recurrent Hepatitis C Virus in Liver Transplant Recipients
Published 2004-01-01Get full text
Article -
264
Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature
Published 2015-01-01“…Invasive fungal infections are very common in solid organ transplants and occur most frequently in the first three months after transplant. …”
Get full text
Article -
265
Two Cases of Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis Caused by Living-Donor Renal Transplantation
Published 2016-01-01“…In rare instances, recipients of organ transplants from human T-lymphotropic virus type I- (HTLV-I-) positive donors reportedly developed neurologic symptoms due to HTLV-I-associated myelopathy (HAM). …”
Get full text
Article -
266
A Knotless Technique for Kidney Transplantation in the Mouse
Published 2012-01-01“…Mouse models of kidney transplantation are important to study molecular mechanisms of organ transplant rejection as well as to develop new therapeutic strategies aimed at improving allograft survival. …”
Get full text
Article -
267
Isolated Sporothrix schenckii Monoarthritis
Published 2018-01-01“…In patients with underlying risk factors (HIV, alcoholism, diabetes mellitus, organ transplant patients, immunosuppressive medications, steroids, and malignancies), it can often have disseminated visceral, osteoarticular, meningeal, and pulmonary involvement. …”
Get full text
Article -
268
Anti-SARS-CoV-2 Antibody Level among Renal Transplant Recipients: A Case Report from Nepal
Published 2022-01-01“…Globally, SARS-CoV-2 has caused significant public health burden, mainly in patients with underlying comorbidities including both communicable and noncommunicable diseases. Solid organ transplant recipients under immunesupressive medication are also amongst the high risk group. …”
Get full text
Article -
269
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
Published 2014-01-01“…Ganciclovir-resistant cytomegalovirus (CMV) is associated with significant morbidity in solid organ transplant recipients. Management of ganciclovir-resistant CMV may be complicated by nephrotoxicity which is commonly observed with recommended therapies and/or rejection induced by “indirect” viral effects or reduction of immunosuppression. …”
Get full text
Article -
270
Herpes simplex virus-2-associated esophagitis in immunocompetent host
Published 2021-01-01“…Common risk factors for HE include a history of HIV, AIDS, malignancy, solid organs transplant, use of steroids, immunosuppressant medications, chemotherapy, and radiation therapy [1, 3–7]. …”
Get full text
Article -
271
Respiratory Failure due to Possible Donor-Derived Sporothrix schenckii Infection in a Lung Transplant Recipient
Published 2015-01-01“…De novo and donor-derived invasive fungal infections (IFIs) contribute to morbidity and mortality in solid organ transplant (SOT) recipients. Reporting of donor-derived IFIs (DDIFIs) to the Organ Procurement Transplant Network has been mandated since 2005. …”
Get full text
Article -
272
Low agreement and frequent invalid controls in two SARS-CoV-2 T-cell assays in people with compromised immune function.
Published 2025-01-01“…For people living with HIV (PWH) and solid organ transplant (SOT) recipients there is limited evidence on the reliability of commercially available T-cell tests. …”
Get full text
Article -
273
Acute Kidney Injury, Recurrent Seizures, and Thrombocytopenia in a Young Patient with Lupus Nephritis: A Diagnostic Dilemma
Published 2016-01-01“…PRES has been associated with multiple conditions such as autoimmune disorders, pregnancy, organ transplant, and thrombotic microangiopathy (TMA). …”
Get full text
Article -
274
Post-COVID Mucormycosis: An Emerging Threat in Developing Countries - A Prospective Review
Published 2024-11-01“…COVID-19 patients with underlying conditions such as diabetes, cancer, or organ transplants are particularly susceptible to mucormycosis due to their immunocompromised state. …”
Get full text
Article -
275
-
276
Conservative Management of Muscle Invasive Bladder Cancer in Kidney-Pancreas Transplant Patient
Published 2022-01-01“…Introduction. Solid organ transplant increases the risk for muscle-invasive bladder cancer (MIBC). …”
Get full text
Article -
277
Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes
Published 2024-10-01“…The likelihood of an indeterminate IGRA was increased in patients with a history of solid organ transplant and a higher severity of COVID-19 at the time of testing. …”
Get full text
Article -
278
Dermatological Disorders following Liver Transplantation: An Update
Published 2019-01-01“…However, the risk is not as high as other solid organ transplantations (SOT), particularly for skin cancer. …”
Get full text
Article -
279
Study of the Prevalence of Cytomegalovirus in Children with Malignancy in Southwestern Iran from 2016-2023
Published 2025-01-01“…This infection is especially dangerous for people with weakened immune systems and patients who have had organ transplants. This study seeks to determine the impact of cytomegalovirus infection on the treatment and survival rate of children with various types of malignancies. …”
Get full text
Article -
280
Brincidofovir Use after Foscarnet Crystal Nephropathy in a Kidney Transplant Recipient with Multiresistant Cytomegalovirus Infection
Published 2017-01-01“…Herein, we present a review of foscarnet nephropathy cases in solid-organ transplanted patients. Conclusions. This unique case highlights the potential benefit of BCV use during resistant CMV infection, although mutations in the UL54 gene may limit its therapeutic efficacy. …”
Get full text
Article